부산대학교 도서관

Munster P; Mita M; Mahipal A; Nemunaitis J; Massard C; Mikkelsen T; Cruz C; Paz-Ares L; Hidalgo M; Rathkopf D; Blumenschein Jr G; Smith DC; Eichhorst B; Cloughesy T; Filvaroff EH; Li S; Raymon H; de Haan H; Hege K; Bendell JC

Cancer Management and Research, Vol 11, Pp 10463-10476 (2019)

Cloughesy T; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; and.; Nathanson DA; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; and.; Czernin J; David Geffen School of Medicine at UCLA, Los Angeles, California.

Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE; In Process

Le Rhun E; Department of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.; Sain D; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Erridge SC; Edinburgh Cancer Centre, University of Edinburgh, Edinburgh, United Kingdom.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy.; Policlinico Umberto I, Rome, Italy.; Roth P; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.; Wick W; Department of Neurology and European Center for Neurooncology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center and German Consortium for Translational Cancer Research, Heidelberg, Germany.; Nabors B; Department of Neurology, University of Alabama at Birmingham, Birmingham.; Sampson J; Department of Neurosurgery, Duke University Medical Center, Preston Robert Tisch Brain Tumor Center at Duke, Durham, North Carolina.; Mason W; Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Cloughesy T; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles.; Reijneveld JC; Department of Neurology & Brain Tumor Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Department of Neurology, Stichting Epilepsie Instellingen Nederland, Heemstede, the Netherlands.; Stupp R; Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Gorlia T; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

van den Bent MJ; The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, Florida, USA.; Cloughesy T; Department of Neurology, UCLA, California, USA.; Galldiks N; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Germany.; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany.; Department of Neurology, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Albert NL; Department of Nuclear Medicine, LMU University Hospital of Munich, Munich, Germany.; Tonn JC; German Cancer Consortium (DKTK), Partner site Munich, Germany.; Department. of Neurosurgery, University Hospital of Munich (LMU), Munich, Germany.; Avila E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, USA.; Fangusaro J; Children's Healthcare of Atlanta, Emory University, and the Aflac Cancer Center, Atlanta, Georgia, USA.; Mirsky D; Department of Radiology, Pediatric Section, University of Colorado School of Medicine, Children's Hospital Colorado, Colorado, USA.; Sahgal A; Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada.; Soffietti R; Division of Neuro-Oncology, Department of Neuroscience 'Rita Levi Montalcini,' University of Turin, Turin, Italy.; Karschnia P; Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University, Erlangen, Germany.; German Cancer Consortium (DKTK), Partner site Munich, Germany.; Department. of Neurosurgery, University Hospital of Munich (LMU), Munich, Germany.; Mehta M; Miami Cancer Institute at Baptist Health of South Florida & Florida International University Department of Radiation Oncology, Miami, Florida, USA.; Kim MM; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.; Boele F; Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds, Leeds, UK.; Leeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK.; Huse JT; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; le Rhun E; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.; Desjardins A; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University, Durham, North Carolina, USA.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Koekkoek JAF; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.; Mendoza T; Office of Patient-Centered Outcomes Research, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA.; Loughan AR; Department of Neurology, Division of Neuro-Oncology, Virginia Commonwealth University, Richmond, Virginia, USA.; Budhu JA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, USA.; Bakas S; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.; Division of Computational Pathology, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.; Huang RY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Villanueva-Meyer JE; Neurological Surgery at University of California, San Francisco, California, USA.; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.; Leone JP; Department of Medical Oncology, Brigham and Women's Hospital Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Okada H; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Neurological Surgery at University of California, San Francisco, California, USA.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Bi WL; Department of Neurosurgery Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, Massachusetts, USA.; Chang SM; Division of NeuroOncology, Department of Neurological Surgery, University of California San Francisco (UCSF), San Francisco, California, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Piotrowski AF; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Shih K; Medical Oncology, Tennessee Oncology, PLLC, Nashville, TN 37203, USA.; Giglio P; Department of Neurology, The Ohio State University, Columbus, OH 43210, USA.; Colman H; Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.; Wen PY; Department of Neurology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Campian JL; Division of Oncology, Washington University, St Louis, MO 63110, USA.; Butowski N; Department of Neuro-Oncology, University of California San Francisco, San Francisco, CA 94143, USA.; Cloughesy T; Department of Neurology, Bowyer Oncology Center, University of California, Los Angeles, CA 90095, USA.; Zhu Z; Clinical Development, BeOne Medicines, Ltd., Ridgefield Park, NJ 07660, USA.; Gisin V; Clinical Development, BeOne Medicines, Ltd., Emeryville, CA 94608, USA.; Badruddoja M; Department of Neurology, Center for Neurosciences, Tucson, AZ 85718, USA.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

Whittle JR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Vieito M; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Rohrberg K; Department of Oncology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.; Rodriguez-Ruiz ME; Oncology, Clinica Universidad de Navarra, Pamplona, Spain.; Castanon E; Oncology, Clinica Universidad de Navarra, Pamplona, Spain.; Mellinghoff IK; Department of Neurology and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA.; Van Linde M; Department of Medical Oncology, Amsterdam University Medical Center, location VU Medical Center, Amsterdam, The Netherlands.; Cloughesy T; Department of Neurology, Ronald Reagan UCLA Medical Center, University of California, Los Angeles, California, USA.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Chong RA; Department of Neurology, Ronald Reagan UCLA Medical Center, University of California, Los Angeles, California, USA.; Rosenthal M; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Wick A; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.; Waldhauer I; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.; Henkel N; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Munich, Germany.; Romagnoli B; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Wolowski V; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Dey S; Roche Products Ltd, Welwyn Garden City, UK.; Heil F; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Munich, Germany.; Heichinger C; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Flinn N; Roche Products Ltd, Welwyn Garden City, UK.; Gou JP; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Smith L; Roche Products Ltd, Welwyn Garden City, UK.; Prince F; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Derks M; Roche Products Ltd, Welwyn Garden City, UK.; Roller A; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Schiff C; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Schneider M; Roche Pharma Research and Early Development, Early Clinical Development Oncology, Roche Innovation Center Basel, Switzerland.; Mason W; Department of Medicine, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

Arrillaga-Romany I; Mass General Cancer Center, Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Lassman A; Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York-Presbyterian Hospital, New York City, New York, USA.; McGovern SL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Mueller S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.; Nabors B; Department of Neuro-Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.; van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Vogelbaum MA; Moffitt Cancer Center, Tampa, Florida, USA.; Allen JE; Chimerix, Inc., Durham, North Carolina, USA.; Melemed AS; Chimerix, Inc., Durham, North Carolina, USA.; Tarapore RS; Chimerix, Inc., Durham, North Carolina, USA.; Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cloughesy T; Bowyer Oncology Center, University of California Los Angeles, Los Angeles, California, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Bagley SJ; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Umemura Y; Department of Neuro-Oncology, Barrow Neurological Institute, Phoenix, AZ 85013, USA.; Mendez JS; Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.; Arrillaga-Romany I; Department of Neuro-Oncology, Massachusetts General Hospital, Boston, MA 02214, USA.; Bielamowicz KJ; Department of Pediatrics, Arkansas Children's Hospital, The University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.; Butowski N; Department of Neuro-Oncology, University of California, San Francisco, CA 94143, USA.; Hutchins K; Department of Hematology/Oncology, Hawaii Pacific Health, Honolulu, HI 96813, USA.; Kong XT; Department of Neurology, University of California Irvine, Irvine, CA 92697, USA.; Odia Y; Miami Cancer Institute, Miami, FL 33176, USA.; Sharma A; Department of Neuro-Oncology, Saint John's Cancer Institute, Pacific Neuroscience Institute, Santa Monica, CA 90404, USA.; Weintraub L; Department of Pediatrics, Albany Medical Center, Albany, NY 12208, USA.; Koschmann C; Department of Pediatric Neuro-Oncology, University of Michigan, Ann Arbor, MI 48109, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Center Institute, Boston, MA 02215, USA.; Saratsis AM; Department of Neurosurgery, Advocate Aurora Healthcare, Chicago, IL 60657, USA.; EB Enterprises, LLC, Chicago, IL 60634, USA.; Brundage T; Chimerix Inc., A Jazz Pharmaceuticals Company, Durham, NC 27713, USA.; Ramage SC; Chimerix Inc., A Jazz Pharmaceuticals Company, Durham, NC 27713, USA.; Tarapore RS; Chimerix Inc., A Jazz Pharmaceuticals Company, Durham, NC 27713, USA.; Knowles T; Department of Neuro-Oncology, University of California, San Francisco, CA 94143, USA.; Yang D; Chimerix Inc., A Jazz Pharmaceuticals Company, Durham, NC 27713, USA.; Allen JE; Chimerix Inc., A Jazz Pharmaceuticals Company, Durham, NC 27713, USA.; Cloughesy T; Department of Neurology, University of California, Los Angeles, CA 90095, USA.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Wirsching HG; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland. hans-georg.wirsching@usz.ch.; Felsberg J; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Düsseldorf, Germany.; Prummer M; NEXUS Personalized Health Technologies and Swiss Institute of Bioinformatics, ETH Zurich, Zurich, Switzerland.; Moisoiu V; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.; Lourman R; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.; Hertler C; Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland.; Antonios M; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.; Cimino PJ; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.; Roth P; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.; Gorlia T; European Organization for Research and Treatment of Cancer, Brussels, Belgium.; Prins RM; Department of Neurosurgery, University of California Los Angeles (UCLA), Los Angeles, CA, USA.; Cloughesy T; Department of Neurosurgery, University of California Los Angeles (UCLA), Los Angeles, CA, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Holland EC; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Reifenberger G; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Düsseldorf, Germany.; Partner Site Essen/Düsseldorf, German Cancer Consortium (DKTK), Düsseldorf, Germany.; Weller M; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

Miller JJ; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Gonzalez Castro LN; Harvard Medical School, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.; McBrayer S; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas, 75235, USA.; Weller M; Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.; Cloughesy T; UCLA Neuro-Oncology Program, Los Angeles, CA, USA.; Portnow J; Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Andronesi O; Harvard Medical School, Boston, MA, USA.; Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.; Barnholtz-Sloan JS; Informatics and Data Science (IDS), Center for Biomedical Informatics and Information Technology (CBIIT), Trans-Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD, USA.; Baumert BG; Cantonal Hospital Graubunden, Institute of Radiation-Oncology, Chur, Switzerland.; Berger MS; Department of Neurosurgery, University of California-San Francisco, San Francisco, California, USA.; Bi WL; Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.; Bindra R; Department of Therapeutic Radiology, Brain Tumor Center, Yale School of Medicine, New Haven, CT, USA.; Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Chang SM; Department of Neurosurgery, University of California-San Francisco, San Francisco, California, USA.; Costello JF; Department of Neurosurgery, University of California-San Francisco, San Francisco, California, USA.; Horbinski C; Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Northwestern Medicine Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Huang RY; Harvard Medical School, Boston, MA, USA.; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Jenkins RB; Individualized Medicine Research, Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, Minnesota 55901, USA.; Ligon KL; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Mellinghoff IK; Department of Neurology, Evnin Family Chair in Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Nabors LB; Department of Neurology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.; Platten M; CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Reardon DA; Harvard Medical School, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.; Shi DD; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Schiff D; Division of Neuro-Oncology, Department of Neurology, University of Virginia Health System, Charlottesville, Virginia, USA.; Wick W; Neuro-Oncology at the German Cancer Research Center (DKFZ), Program Chair of Neuro-Oncology at the National Center for Tumor Diseases (NCT), and Neurology and Chairman at the Neurology Clinic in Heidelberg, Heidelberg, Germany.; Yan H; Genetron Health Inc, Gaithersburg, Maryland 20879, USA.; von Deimling A; Department of Neuropathology, University Hospital Heidelberg, and, Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), and, DKTK, INF 224, 69120 Heidelberg, Germany.; van den Bent M; Brain Tumour Centre, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.; Kaelin WG; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Wen PY; Harvard Medical School, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Omuro A; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Brandes AA; AUSL-IRCCS Institute of Neurological Sciences, Bologna, Italy.; Carpentier AF; Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Service de Neurologie, Paris, France.; Idbaih A; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Hôpital Universitaire La Pitié Salpêtrière, DMU Neurosciences, Paris, France.; Reardon DA; Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Cloughesy T; Department of Neurology, University of California, Los Angeles, California, USA.; Sumrall A; Levine Cancer Institute, Charlotte, North Carolina, USA.; Baehring J; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.; van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Bähr O; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.; Lombardi G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Mulholland P; University College London Hospitals, London, UK.; Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany.; Lassen U; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.; Sepulveda JM; Hospital Universitario 12 de Octubre, Madrid, Spain.; Khasraw M; The University of Sydney, Sydney, New South Wales, Australia.; Vauleon E; Centre Eugene Marquis, Rennes, France.; Muragaki Y; Tokyo Women's Medical University Hospital, Tokyo, Japan.; Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; Butowski N; Department of Neurological Surgery, University of California, San Francisco, California, USA.; Roth P; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; Qian X; Bristol Myers Squibb, Princeton, New Jersey, USA.; Fu AZ; Bristol Myers Squibb, Princeton, New Jersey, USA.; Liu Y; Bristol Myers Squibb, Princeton, New Jersey, USA.; Potter V; Bristol Myers Squibb, Princeton, New Jersey, USA.; Chalamandaris AG; Bristol Myers Squibb, Braine-L'Alleud, Belgium.; Tatsuoka K; Bristol Myers Squibb, Princeton, New Jersey, USA.; Lim M; The Johns Hopkins Hospital, Baltimore, Maryland, USA.; Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Sloan AE; Chief of Neuroscience, Piedmont Healthcare, Atlanta, USA. Andrew.Sloan@Piedmont.org.; Nock CJ; Department of Medicine, UH-Seidman Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH, USA.; Ye X; Adult Brain Tumor Consortium, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Buerki R; Department of Neurology, UH-Seidman Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH, USA.; Chang S; Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA.; Lesser G; Department of Radiation Oncology, Wake Forest University, Wake Forest, NC, USA.; Norden A; Department of Medicine, Dana Farber Cancer Institute, Boston, MA, USA.; Cloughesy T; Department of Neurology, University of California, Los Angeles, Los Angeles, CA, USA.; Olson J; Department of Neurosurgery, Emory University, Atlanta, GA, USA.; Kerstetter-Fogle A; Chief of Neuroscience, Piedmont Healthcare, Atlanta, USA.; Rich J; Department of Neurology and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Fisher J; Adult Brain Tumor Consortium, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Desideri S; Adult Brain Tumor Consortium, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Takebe N; National Cancer Institute, Clinical Investigations Branch, National Institutes of Health, Bethesda, MD, USA.; Timmer W; National Cancer Institute, Clinical Investigations Branch, National Institutes of Health, Bethesda, MD, USA.; Grossman S; Adult Brain Tumor Consortium, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Prados M; Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA.

Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

Arrillaga-Romany I; Massachusetts General Hospital, Boston, MA.; Gardner SL; New York University, Grossman School of Medicine, New York, NY.; Odia Y; Miami Cancer Institute, part of Baptist Health South Florida, Miami, FL.; Aguilera D; Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA.; Allen JE; Chimerix, Inc, Durham, NC.; Batchelor T; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.; Butowski N; University of California, San Francisco, CA.; Chen C; University of Minnesota Medical Center, Minneapolis, MN.; Cloughesy T; University of California, Los Angeles, CA.; Cluster A; Washington University of St Louis, St Louis, MO.; de Groot J; University of California, San Francisco, CA.; Dixit KS; Northwestern Medical Lou and Jean Malnati Brain Tumor Institute, Chicago, IL.; Graber JJ; University of Washington Medical Center, Seattle, WA.; Haggiagi AM; Columbia University Irving Medical Center, New York, NY.; Harrison RA; BC Cancer, The University of British Columbia, Vancouver, BC, Canada.; Kheradpour A; Loma Linda University, Loma Linda, CA.; Kilburn LB; Children's National Hospital, Washington, DC.; Kurz SC; University Hospital Tuebingen, Tuebingen, Germany.; Lu G; Oncoceutics Inc, Philadelphia, PA.; MacDonald TJ; Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA.; Mehta M; Miami Cancer Institute, part of Baptist Health South Florida, Miami, FL.; Melemed AS; Chimerix, Inc, Durham, NC.; Nghiemphu PL; University of California, Los Angeles, CA.; Ramage SC; Chimerix, Inc, Durham, NC.; Shonka N; University of Nebraska Medical Center, Omaha, NE.; Sumrall A; Levine Cancer Institute, Charlotte, NC.; Tarapore RS; Chimerix, Inc, Durham, NC.; Taylor L; University of Washington Medical Center, Seattle, WA.; Umemura Y; University of Michigan, Ann Arbor, MI.; Wen PY; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Lee AH; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Sun L; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Mochizuki AY; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Reynoso JG; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Orpilla J; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Chow F; Department of Neurology/Neuro-Oncology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Kienzler JC; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Everson RG; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Nathanson DA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Bensinger SJ; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Liau LM; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Cloughesy T; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Department of Neurology/Neuro-Oncology, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA.; Hugo W; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA. HWilly@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, 1 Letterman Drive, Suite D3500, San Francisco, CA, 94129, USA. HWilly@mednet.ucla.edu.; Department of Medicine/Dermatology, University of California, Los Angeles, Los Angeles, CA, 90095, USA. HWilly@mednet.ucla.edu.; Prins RM; Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, 90095, USA. RPrins@mednet.ucla.edu.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA. RPrins@mednet.ucla.edu.; UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, 90095, USA. RPrins@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, 1 Letterman Drive, Suite D3500, San Francisco, CA, 94129, USA. RPrins@mednet.ucla.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Nayak L; DeAngelis LM; Brandes AA; Peereboom DM; Galanis E; Lin NU; Soffietti R; Macdonald DR; Chamberlain M; Perry J; Jaeckle K; Mehta M; Stupp R; Muzikansky A; Pentsova E; Cloughesy T; Iwamoto FM; Tonn JC; Vogelbaum MA; Wen PY; van den Bent MJ; Reardon DA

Neuro-Oncology. 19:625-635

Chuntova P; Department of Neurological Surgery, UCSF, San Francisco, California.; Chow F; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Watchmaker PB; Department of Neurological Surgery, UCSF, San Francisco, California.; Galvez M; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, Los Angeles, California.; Heimberger AB; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Diaz A; Department of Neurological Surgery, UCSF, San Francisco, California.; DePinho RA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Li MO; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Wherry EJ; Department of Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Mitchell D; Department of Neurosurgery, University of Florida College of Medicine, Gainesville, Florida.; Terabe M; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.; Wainwright DA; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.; Berzofsky JA; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.; Herold-Mende C; Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany.; Heath JR; Institute for Systems Biology, Seattle, Washington.; Lim M; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Margolin KA; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.; Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts.; Kasahara N; Department of Neurological Surgery, UCSF, San Francisco, California.; Ellingson BM; Department of Radiological Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California.; Brown CE; Department of Immuno-Oncology, Beckman Research Institute of the City of Hope, Duarte, California.; Chen Y; Department of Microbiology, Immunology & Molecular Genetics, UCLA, Los Angeles, California.; Fecci PE; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina.; Reardon DA; Department of Medicine/Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Dunn GP; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri.; Liau LM; Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California.; Costello JF; Department of Neurological Surgery, UCSF, San Francisco, California.; Wick W; Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.; Cloughesy T; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Timmer WC; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Prins RM; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, Los Angeles, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Platten M; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany.; DKTK CCU Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Okada H; Department of Neurological Surgery, UCSF, San Francisco, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Friedman HS; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Prados MD; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Wen PY; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Mikkelsen T; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Schiff D; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Abrey LE; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Yung WKA; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Paleologos N; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Nicholas MK; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Jensen R; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Vredenburgh J; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Huang J; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Zheng M; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Cloughesy T; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE

Reardon DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. david_reardon@dfci.harvard.edu.; Desjardins A; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Rixe O; Quantum Santa Fe, Santa Fe, NM, USA.; Cloughesy T; Department of Neurology, University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Alekar S; Pfizer Inc, New York, NY, USA.; Williams JH; Pfizer Inc, New York, NY, USA.; Li R; Pfizer Inc, New York, NY, USA.; Taylor CT; Pfizer Inc, New York, NY, USA.; Lassman AB; Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.

Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Reardon DA; Cloughesy T; Rich J; Alfred Yung WK; Yung L; Dilea C; Huang J; Dugan M; Mietlowski W; Maes A; Conrad C

Cancer Chemotherapy & Pharmacology. Jan2012, Vol. 69 Issue 1, p281-287. 7p.

Pope WB; Xia Q; Paton VE; Das A; Hambleton J; Kim HJ; Huo J; Brown MS; Goldin J; Cloughesy T; Pope, W B; Xia, Q; Paton, V E; Das, A; Hambleton, J; Kim, H J; Huo, J; Brown, M S; Goldin, J; Cloughesy, T

Neurology. 2/1/2011, Vol. 76 Issue 5, p432-437. 6p.